Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

220.59

198.76

182.92

209.90

159.76

Operating profit

35.92

23.70

22.14

39.69

13.66

Interest

3.54

3.80

5.55

7.48

7.68

Gross profit

39.81

28.08

18.48

33.93

14.91

EPS (Rs)

6.02

3.99

2.12

15.89

1.65

Other income

7.44

8.18

1.89

1.73

8.93

Stock adjustment

-13.68

4.47

-6.34

14.69

18.85

Raw material

135.62

117.86

118.41

104.22

76.75

Power and fuel

-

-

-

-

-

Employee expenses

18.66

17.19

16.22

16.36

16.68

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

44.07

35.53

32.49

34.95

33.82

Provisions made

-

-

-

-

-

Depreciation

9.27

7.84

7.71

7.21

8.18

Taxation

-

-

-

-

-

Net profit / loss

30.55

20.24

10.78

64.87

6.73

Extra ordinary item

-

-

-

38.15

-

Prior year adjustments

-

-

-

-

-

Equity capital

50.72

50.72

50.72

40.82

40.82

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

16.28

11.92

12.10

18.91

8.55

GPM (%)

17.46

13.57

10.00

16.03

8.84

NPM (%)

13.40

9.78

5.83

30.65

3.99